SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids?
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved..
BACKGROUND AND AIMS: Administration of corticosteroids is common in obstetric practice. In this concise review we queried on the effects of corticosteroids in pregnancies complicated by SARS-CoV-2.
METHODS: We performed a literature search on PubMed, regarding the use of corticosteroids in patients with SARS-CoV-2 infection, in pregnancies complicated by SARS-CoV-2, as well as their impact on glycemia in pregnant women with or without diabetes. Furthermore, we searched for effects of SARS-CoV-2 and of other coronaviridae on insulin secretion and glycemia.
RESULTS: SARS-CoV-2 infection appears to be a risk factor for complications in pregnancy. Corticosteroids may not be recommended for treating SARS-CoV-2 pneumonia but they may be needed for at-risk pregnancies. Corticosteroids in pregnancy have a diabetogenic potential. SARS-CoV-2 and other coronaviridae may have effects on glycemia.
CONCLUSIONS: Caution should be exercised while using corticosteroids in pregnant women with COVID-19 requiring preterm delivery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Diabetes & metabolic syndrome - 14(2020), 4 vom: 05. Juli, Seite 519-520 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kakoulidis, Ioannis [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenal Cortex Hormones |
---|
Anmerkungen: |
Date Completed 28.07.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.dsx.2020.04.045 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309715377 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309715377 | ||
003 | DE-627 | ||
005 | 20231225134527.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.dsx.2020.04.045 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM309715377 | ||
035 | |a (NLM)32388332 | ||
035 | |a (PII)S1871-4021(20)30110-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kakoulidis, Ioannis |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids? |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.07.2020 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a BACKGROUND AND AIMS: Administration of corticosteroids is common in obstetric practice. In this concise review we queried on the effects of corticosteroids in pregnancies complicated by SARS-CoV-2 | ||
520 | |a METHODS: We performed a literature search on PubMed, regarding the use of corticosteroids in patients with SARS-CoV-2 infection, in pregnancies complicated by SARS-CoV-2, as well as their impact on glycemia in pregnant women with or without diabetes. Furthermore, we searched for effects of SARS-CoV-2 and of other coronaviridae on insulin secretion and glycemia | ||
520 | |a RESULTS: SARS-CoV-2 infection appears to be a risk factor for complications in pregnancy. Corticosteroids may not be recommended for treating SARS-CoV-2 pneumonia but they may be needed for at-risk pregnancies. Corticosteroids in pregnancy have a diabetogenic potential. SARS-CoV-2 and other coronaviridae may have effects on glycemia | ||
520 | |a CONCLUSIONS: Caution should be exercised while using corticosteroids in pregnant women with COVID-19 requiring preterm delivery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Betamethasone | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a Hyperglycemia | |
650 | 4 | |a Insulin | |
650 | 4 | |a SARS-CoV-2 | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
700 | 1 | |a Ilias, Ioannis |e verfasserin |4 aut | |
700 | 1 | |a Koukkou, Eftychia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes & metabolic syndrome |d 2007 |g 14(2020), 4 vom: 05. Juli, Seite 519-520 |w (DE-627)NLM189445564 |x 1878-0334 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2020 |g number:4 |g day:05 |g month:07 |g pages:519-520 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dsx.2020.04.045 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2020 |e 4 |b 05 |c 07 |h 519-520 |